Hudson River Biotechnology

Private

WageningenHealthcare & Life Scienceshttps://www.hudsonriver.bio/

Last Round

VC Round

Apr 9, 2024

Total Funding Raised

$5.99M

Company Overview

Hudson River Biotechnology is an agricultural biotechnology company that develops new crop varieties using its proprietary DNA-free CRISPR platform.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, ML Platforms

Business Model

B2B

Customer Profile

Services & Consulting, Revenue Share, Government Contracts

AI Layer

Application

Keywords

CRISPRgene editingDNA-free CRISPRagricultural biotechnologyagritechagbiotechcrop improvementplant gene editingtrait developmentprecision breedingprotoplast technologyseed companiesgenetic target identificationclimate resilient cropsornamental plantsnanotechnology deliverybioinformatics

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Hudson River Biotechnology Comps

Public and private peers based on sector, stage, and business model.

Hudson River Biotechnology comps — public and private peers by sector, stage, and business model
Company	Status	Est. Valuation	Rev Multiple
OpenAI	Private	$86.0B	~40x
Cohere	Private	$5.0B	--
Competitor 1	Public	$XX.XB	XXx
Competitor 2	Public	$XX.XB	XXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Hudson River Biotechnology Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
VC Round	Apr 9, 2024
VC Round	Apr 9, 2024
Series A	Aug 5, 2021
Seed	Mar 21, 2018
Grant	Mar 18, 2015

View all Funding Rounds

Key People

Founding team and executive leadership

Ferdinand Los

Chief Executive Officer

Executive Team

Hudson River Biotechnology Investors

Notable investors and investment history

Hudson River Biotechnology investors
Investor	Rounds
Horizon 2020	Grant
Bridford Group	VC Round, Series A
Oost NL	VC Round
StartLife	Series A

View all Investors

Market signals

Structured signals derived from secondary market and firmographic data.

Apr 9, 2024
Oost NL and Bridford Group led the round.
Apr 9, 2024
Oost NL and Bridford Group led the round.

View all signals

Hudson River Biotechnology Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

Hudson River Biotechnology Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Hudson River Biotechnology's valuation, stock price, and market status.

Firmographic Details

HeadquartersWageningen

Employee Range22

Year Founded2015

Last FundingApr 9, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.